About Science 37
Science 37 is a Healthcare company based in Los Angeles (United States) founded in 2014, and was acquired by eMed Technologies in January 2024. Provider of a suite solution for clinical trials for researchers. Science 37 has raised $106.5 million across 4 funding rounds from investors including Amgen, Novartis and PPD. Its chief executive, as recorded, is David Coman. Its website science37.com draws about 29 thousand monthly visits. Science 37 offers products and services including Metasite Platform and Patient Recruitment. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Clinical Trials. Its competitors include Medidata, Verily and IQVIA; 2 of its 3 listed competitors have raised funding.
Company details
Science 37 was founded in 2014 and is headquartered in Los Angeles, United States. Operations focus on the clinical trials sector, where end-to-end solutions are delivered to support researchers. A mobile platform enables patient participation, while tools like Metasite facilitate site-based data collection, trial management, and communication. Additional features include recruitment systems, patient enrollment processes, and virtualization for study design concepts.
- Headquarters Los Angeles, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website science37.com
- Social LinkedIn X Facebook
- Acquired by eMed Technologies (Jan 2024)
- Total Equity Funding$106.5M (USD)
in 4 rounds
- Latest Funding Round$40M (USD), Series D
Aug 2020
- InvestorsAmgen
& 11 more
- Acquired byeMed Technologies
(Jan 2024)
Products & Services of Science 37
Science 37 offers a comprehensive portfolio of products and services, including Metasite Platform and Patient Recruitment.
Enables remote clinical trials for broader patient access and data collection
Facilitates diverse participant enrollment in clinical studies remotely
Apps and channels of Science 37
Science 37 publishes 1 mobile app with over 10K+ downloads.
Funding Insights of Science 37
Science 37 has successfully raised a total of $106.5M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $40 million completed in August 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $106.5M
- Total Rounds 4
- Last Round Series D — $40M
- First Round $6.5M
(Oct 2015)
- Investors Count 11
All 4 funding rounds of Science 37 with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2020 | $40M | Series D | – | Lux Capital, Redmile Group | |
| Apr 2017 | $29M | Series C | – | Glynn Capital | |
| Oct 2016 | $31M | Series B | – | Redmile Group | |
| Oct 2015 | $6.5M | Series A | – | dRx Capital, Lux Capital |
12 investors in total: 12 institutional.
Investors in Science 37
Science 37 has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include Amgen, Novartis and PPD.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Seed and early-stage technology companies are funded by Lux Capital. | luxcapital.com | Menlo Park, United States | ||
Corporate backed venture capital fund investing in multiple sectors | gv.com | Mountain View, United States | ||
Investments are directed toward early and late-stage tech companies. | glynncapital.com | Menlo Park, United States | ||
Life-Sciences focused Early stage Corporate VC Firm investing in the US | sanofiventures.com | Paris, France | ||
Healthcare startups are funded by this corporate-backed venture capital entity. | lifesciventure.com | New York, United States | ||
Early-stage investments in US Tech and Life Sciences are targeted. | drxcapital.com | Basel, Switzerland | ||
Operates as an employee-owned hedge fund focused on long/short equity strategies. | 2007 | redmilegroup.com | San Francisco, United States | |
CRO providing diversified clinical development services | 1985 | ppd.com | Wilmington, United States | |
R&D focused on manufacturing of drugs for multiple therapeutic areas | 1996 | novartis.com | Basel, Switzerland | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | amgen.com | Thousand Oaks, United States |
Investor details for Science 37
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Science 37
85 people are tracked at Science 37 (27 in leadership, 3 in board & advisors, 55 in team).
| Name | Role | Group |
|---|---|---|
David Coman | CEO | Leadership |
Sara Trepanier M.D. | Medical Director, Emergency Medicine | Leadership |
David Kudrow | Medical Director, Neurology | Leadership |
Tyler Van Horn | VP, Corporate Strategy & Chief of Staff | Leadership |
Scott Arceri | Vice President, Strategic Solutions | Leadership |
Mark Hanson | Senior Director, Strategic Business Development | Leadership |
Irena Lambridis | VP & Head, Quality Assurance & Compliance | Leadership |
Austin Crafts | Director Of Engineering | Leadership |
Joel Parks | Director: Cloud, Site Reliability Engineering And Release Engineering | Leadership |
Leonard White | Director Of Data And Enterprise Applications | Leadership |
Elizabeth Cleale | Senior Director, Human Resources | Leadership |
Alina Wherry (Dawson) | Director Of Clinical Operations | Leadership |
Samisha Thomas-Hans | Senior Director, Real-world Evidence | Leadership |
Dave Chen | Director Of Technology | Leadership |
Michael Biron | Senior Director, Strategic Solutions | Leadership |
Mikolaj K. | Business Partner | Leadership |
Jeffrey Golden | Senior Director Of Strategic Solutions | Leadership |
Adam Noe | Director, Strategic Solutions | Leadership |
Nicole Tinfo | Sr. Director, Clinical Research | Leadership |
Christiane Dinneen | Vice President Clinical Operations | Leadership |
65 more people are available in the full profile.
Complete people profiles for Science 37
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Science 37
5 dated milestones of Science 37 across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Science 37 is founded.
- Funding First funding round of $6.5M.
- Funding Latest funding round, Series D, of $40.0M.
- IPO Lists on the stock exchange (IPO).
- Exit Acquired by eMed Technologies.
Competitors of Science 37
Science 37 has 3 listed competitors in our database, 2 of them funded. They include Medidata, Verily and IQVIA.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| medidata.com | 1999 | New York, United States | $41.5M | 1,677 | Medidata is recognized as a leading provider of SaaS solutions for clinical research. | |
| verily.com | 2015 | Dallas, United States | $2.5B | AI-based solutions for health management are provided. | ||
| iqvia.com | 1982 | Durham, United States | 88,000 | Clinical research and commercialization solutions are provided for healthcare. |
Detailed competitors of Science 37
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Science 37
The website of Science 37 (science37.com) receives about 29.3K visits a month.
- Monthly visits29.3K
▲ 7.6% vs previous month
Websites whose visitors overlap most with Science 37. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| vaulthealth.com | 100% | 7.3K | #3,108,379 | View details | |
| medcitynews.com | 82% | 128.8K | #363,034 | View details | |
cellandgene.com | cellandgene.com | 68% | #1,018,368 | – | |
| medidata.com | 49% | 87K | #373,122 | View details |
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Science 37 (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Science 37
Complete news archive for Science 37
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Science 37
Science 37 was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Science 37 is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
David Coman is the CEO of Science 37, as recorded in our data.
Science 37 is a funded company, having raised a total of $106.5M across 4 funding rounds to date. The company's 1st funding round was a Series A of $6.5M, raised on Oct 2015.
Science 37 was founded in 2014 and is headquartered in Los Angeles, United States. Operations focus on the clinical trials sector, where end-to-end solutions are delivered to support researchers. A mobile platform enables patient participation, while tools like Metasite facilitate site-based data collection, trial management, and communication. Additional features include recruitment systems, patient enrollment processes, and virtualization for study design concepts.
Science 37 offers Metasite Platform and Patient Recruitment.
Science 37 has 12 investors. Key investors include Amgen, Novartis, PPD, Mubadala, and eMed Technologies.
Yes. Science 37 was acquired by eMed Technologies in January 2024.
Yes. Science 37 publishes Science 37 Clinical Research, with over 10,000 downloads.

